Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
86 studies found for:    "retinitis pigmentosa"
Show Display Options
Rank Status Study
21 Completed Randomized Trial for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Vitamin A;   Drug: Nutritional Supplement
22 Recruiting Biomarkers In Retinitis Pigmentosa (BIRP)
Condition: Retinitis Pigmentosa Patients
Intervention: Other: AC tap
23 Completed Effects of Lutein in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: Lutein (10 or 30 mg/day) capsules
24 Active, not recruiting DHA and X-Linked Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   X-linked Genetic Diseases
Intervention: Drug: docosahexaenoic acid OR corn/soy oil placebo
25 Completed Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Device: transcorneal electrostimulation
26 Completed Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Procedure: hyperbaric oxygen therapy
27 Recruiting Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Biological: Intravitreal injection of Autologous bone marrow Stem Cell;   Other: Subconjunctival injection of saline
28 Active, not recruiting Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: UF-021;   Drug: Placebo
29 Not yet recruiting The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions in Adolescent Patients With Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Dietary Supplement: Alga Dunaliella Bardawil powder;   Dietary Supplement: Placebo:Starch
30 Not yet recruiting Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa (RP)
Intervention: Biological: human retinal progenitor cells
31 Completed Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)
Condition: Retinitis Pigmentosa (RP)
Intervention: Drug: QLT091001
32 Recruiting Natural History and Genetic Studies of Usher Syndrome
Conditions: Retinitis Pigmentosa Syndromic;   Congenital Deafness;   Usher Syndrome;   Retinitis Pigmentosa and Deafness;   Progressive Hearing Loss;   Retinitis Pigmentosa
Intervention:
33 Completed Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)
Conditions: LCA (Leber Congenital Amaurosis);   RP (Retinitis Pigmentosa)
Intervention: Drug: QLT091001
34 Completed Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
Conditions: LCA (Leber Congenital Amaurosis);   RP (Retinitis Pigmentosa)
Intervention: Drug: QLT091001
35 Active, not recruiting Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Retinal Diseases;   Eye Diseases;   Eye Disease, Hereditary;   Retinal Degeneration
Intervention: Drug: Valproic Acid
36 Completed Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Vitamin E;   Drug: Vitamin A
37 Terminated Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome
Conditions: Usher Syndrome;   Retinitis Pigmentosa
Intervention:
38 Completed Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: docosahexaenoic acid
39 Completed Evaluation of Objective Perimetry Using Pupillometer
Conditions: Retinitis Pigmentosa;   Glaucoma;   Visual Field
Intervention:
40 Completed The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction
Conditions: Retinitis Pigmentosa;   Cataract
Intervention: Procedure: IOL surgery

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years